Development
Evaxion Biotech A/S
EVAX
$3.13
$0.5521.32%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
6/3/2025
-
Globe Newswire
5/29/2025
-
TipRanks Financial Blog
5/28/2025
-
Insider Monkey
5/28/2025
-
TipRanks Financial Blog
5/27/2025
-
Seeking Alpha: Transcripts
5/27/2025
-
SeekingAlpha
5/27/2025
-
Globe Newswire
5/23/2025
-
Globe Newswire
5/22/2025
-
Globe Newswire
5/20/2025
-
Accesswire
4/28/2025
-
Globe Newswire
4/10/2025
-
Globe Newswire
4/3/2025
-
TipRanks Financial Blog
4/2/2025
-
GuruFocus
4/2/2025
-
TipRanks Financial Blog
4/1/2025
-
SeekingAlpha
4/1/2025
-
Seeking Alpha: Transcripts
4/1/2025
-
SeekingAlpha
4/1/2025
-
Globe Newswire
3/27/2025
-
Globe Newswire
3/25/2025
-
Globe Newswire
3/17/2025
-
Ticker Report
3/4/2025
-
Globe Newswire
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Wednesday, August 14, 2024
Period Date
Sunday, June 30, 2024
Next Filing
(est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
45 31 31 97 53
Address
Dr. Neergaards Vej
Horsholm, 2970
Horsholm, 2970
Country
Year Founded
Business Description
Sector
Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies. The company develops EVX-01, which is in phase 2 global multi-center...
more